Back

Prediction of worsening heart failure in patients with hypertrophic cardiomyopathy using plasma proteomics profiling

27 August 2022 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session in Clinical Cardiology Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Lusha Liang

Columbia University Medical Centre, New York (United States of America)

3 More presentations in this session

Presentation thumbnail
Risk stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: the impact of genotype on the 2019 ARVC risk calculator
Doctor A. Protonotarios (London, GB)
Abstract Slides Video
Presentation thumbnail
Expanded adaptation of an artificial intelligence model for predicting chemotherapy-induced cardiotoxicity using baseline electrocardiograms
Doctor R. Yagi (Boston, US)
Abstract Slides Video
Presentation thumbnail
Sudden cardiac death during exercise in young individuals with hypertrophic cardiomyopathy
Doctor R. Bhatia (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Clinical Cardiology

The Event

Event poster

ESC Congress 2022

27 August 2022 13:30 CET
You may be interested in
thumbnail
Congress Session
Biomarkers in the era of 'OMICS': potential beyond diagnosis
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Presentation
Proteomic analysis of potential biomarkers of recent onset dilated cardiomyopathy for prediction of the therapy outcome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources